Cargando…
21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery
Introduction: To assess the role of the 21-gene recurrence score (RS) assay on decision-making of postoperative radiotherapy (RT) following breast-conserving surgery (BCS) in elderly women with early-stage breast cancer. Methods: The 21-gene RS for elderly (≥65 years) women with stage T1–2N0M0 estro...
Autores principales: | Wu, San-Gang, Zhang, Wen-Wen, Wang, Jun, Dong, Yong, Sun, Jia-Yuan, Chen, Yong-Xiong, He, Zhen-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361832/ https://www.ncbi.nlm.nih.gov/pubmed/30761267 http://dx.doi.org/10.3389/fonc.2019.00001 |
Ejemplares similares
-
21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer
por: Zhang, Wen-Wen, et al.
Publicado: (2019) -
Omission of Postoperative Radiotherapy in Women Aged 65 Years or Older With Tubular Carcinoma of the Breast After Breast-Conserving Surgery
por: Wu, San-Gang, et al.
Publicado: (2018) -
The addition of radiotherapy to breast-conserving surgery improves survival for elderly patients with early breast cancer
por: Yang, Shi-Ping, et al.
Publicado: (2022) -
Effect of adjuvant radiotherapy after breast-conserving surgery in elder women with early-stage breast cancer: a propensity-score matching analysis
por: Han, Tingting, et al.
Publicado: (2023) -
Effect of 21-gene recurrence score in decision-making for surgery in early stage breast cancer
por: Wu, San-Gang, et al.
Publicado: (2019)